Gold futures on Monday finished sharply lower, notching the sharpest daily fall since early November, as investors unloaded the metal amid news on prospective vaccines and treatments for COVID-19 that broke down near-term support for bullion.
Drugmaker AstraZeneca said a study found the vaccine it is developing with the University of Oxford had an up to 90% efficacy rate. That news followed similarly upbeat vaccine news from Pfizer and its partner BioNTech, as well as from drugmaker Moderna earlier this month.
Distribution of vaccines could begin to front line workers yet this year, once the Food and Drug Administration grants approval, according to the head of Operation Warp Speed.
Vaccine progress has been a drag on bullion because it undercuts the haven appeal for gold and silver, dealers say.
Gold isnt particularly fond of all this vaccine news, wrote Craig Erlam, senior market analyst at Oanda, in a research note.
On Monday, December gold GCZ20, 0.16% GOLD, -1.93% shed $34.60, or 1.8%, to settle at $1,837.80 an ounce, after putting in a weekly of 0.7% on Friday, its second consecutive, according to FactSet data. The metal booked its worst daily decline since Nov. 9 and also marked its lowest closing level since July 20, according to Dow Jones Market Data, based on the most-active contract.
https://www.marketwatch.com/story/gold-prices-retreat-as-vaccine-progress-hurts-metals-appeal-11606135659
An Indo-American News website. It covers Gossips, Politics, Movies, Technolgy, and Sports News and Photo Galleries and Live Coverage of Events via Youtube. The website is established in 2015 and is owned by AGK FIRE INC.
Gold futures on Monday finished sharply lower, notching the sharpest daily fall since early November, as investors unloaded the metal amid news on prospective vaccines and treatments for COVID-19 that broke down near-term support for bullion. Drugmaker AstraZeneca said a study found the vaccine it is developing with the University of Oxford had an up to 90% efficacy rate. That news followed similarly upbeat vaccine news from Pfizer and its partner BioNTech, as well as from drugmaker Moderna earlier this month. Distribution of vaccines could begin to front line workers yet this year, once the Food and Drug Administration grants approval, according to the head of Operation Warp Speed. Vaccine progress has been a drag on bullion because it undercuts the haven appeal for gold and silver, dealers say. Gold isnt particularly fond of all this vaccine news, wrote Craig Erlam, senior market analyst at Oanda, in a research note. On Monday, December gold GCZ20, 0.16% GOLD, -1.93% shed $34.60, or 1.8%, to settle at $1,837.80 an ounce, after putting in a weekly of 0.7% on Friday, its second consecutive, according to FactSet data. The metal booked its worst daily decline since Nov. 9 and also marked its lowest closing level since July 20, according to Dow Jones Market Data, based on the most-active contract. https://www.marketwatch.com/story/gold-prices-retreat-as-vaccine-progress-hurts-metals-appeal-11606135659
This website uses cookies.